Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Neuroscience20 (Brain20, Spine20, and Mental20) Health Initiative: A Global Consortium Addressing the Human and Economic Burden of Brain, Spine, and Mental Disorders Through Neurotech Innovations and Policies Publisher Pubmed



Morris K1, 2 ; Nami M1, 3, 4, 60 ; Bolanos JF1, 2 ; Lobo MA1, 2 ; Sadrinaini M1, 2 ; Fiallos J1, 2 ; Sanchez GE1, 2 ; Bustos T1, 2 ; Chintam N1, 2 ; Amaya M1, 2 ; Strand SE1, 2 ; Mayukudore A1, 2 ; Sakibova I1, 2 ; Biso GMN1, 2 Show All Authors
Authors
  1. Morris K1, 2
  2. Nami M1, 3, 4, 60
  3. Bolanos JF1, 2
  4. Lobo MA1, 2
  5. Sadrinaini M1, 2
  6. Fiallos J1, 2
  7. Sanchez GE1, 2
  8. Bustos T1, 2
  9. Chintam N1, 2
  10. Amaya M1, 2
  11. Strand SE1, 2
  12. Mayukudore A1, 2
  13. Sakibova I1, 2
  14. Biso GMN1, 2
  15. Defilippis A1, 2
  16. Bravo D1, 2
  17. Tarhan N1, 4, 5
  18. Claussen C1, 6
  19. Mercado A1, 7
  20. Braun S8
  21. Yuge L1, 9, 10
  22. Okabe S11
  23. Taghizadehhesary F12
  24. Kotliar K13
  25. Sadowsky C14
  26. Chandra PS15
  27. Tripathi M16
  28. Katsaros V17, 18, 19
  29. Mehling B20, 61
  30. Noroozian M4, 21
  31. Abbasioun K4, 22
  32. Amirjamshidi A4, 22
  33. Hosseinzadeh GA4, 23
  34. Naraghi F4, 24
  35. Barzegar M4, 25
  36. Asadipooya AA4, 26, 27
  37. Sahabnegah S4, 28, 62
  38. Sadeghian S4, 29
  39. Fahnestock M30
  40. Dilbaz N5
  41. Hussain N1, 31
  42. Mari Z1, 32
  43. Thatcher RW1, 33, 34
  44. Sipple D1, 2, 6
  45. Sidhu K1, 2, 35, 36, 37
  46. Chopra D38
  47. Costa F39, 40
  48. Spena G41
  49. Berger T1, 42
  50. Zelinsky D1, 43
  51. Wheeler CJ1, 12
  52. Ashford JW1, 44
  53. Schulte R1, 31
  54. Nezami MA45
  55. Kloor H1, 46
  56. Filler A1, 2, 47
  57. Eliashiv DS1, 48
  58. Sinha D1
  59. Desalles AAF49, 50, 51
  60. Sadanand V1, 2
  61. Suchkov S34, 52
  62. Green K1, 2
  63. Metin B4, 5
  64. Hariri R1, 2, 53, 54
  65. Cormier J1, 55
  66. Yamamoto V1, 2, 56, 57
  67. Kateb B4, 31, 58, 59

Source: Journal of Alzheimer's Disease Published:2021


Abstract

Neurological disorders significantly impact the world's economy due to their often chronic and life-threatening nature afflicting individuals which, in turn, creates a global disease burden. The Group of Twenty (G20) member nations, which represent the largest economies globally, should come together to formulate a plan on how to overcome this burden. The Neuroscience-20 (N20) initiative of the Society for Brain Mapping and Therapeutics (SBMT) is at the vanguard of this global collaboration to comprehensively raise awareness about brain, spine, and mental disorders worldwide. This paper aims to provide a comprehensive review of the various brain initiatives worldwide and highlight the need for cooperation and recommend ways to bring down costs associated with the discovery and treatment of neurological disorders. Our systematic search revealed that the cost of neurological and psychiatric disorders to the world economy by 2030 is roughly $16T. The cost to the economy of the United States is $1.5T annually and growing given the impact of COVID-19. We also discovered there is a shortfall of effective collaboration between nations and a lack of resources in developing countries. Current statistical analyses on the cost of neurological disorders to the world economy strongly suggest that there is a great need for investment in neurotechnology and innovation or fast-tracking therapeutics and diagnostics to curb these costs. During the current COVID-19 pandemic, SBMT, through this paper, intends to showcase the importance of worldwide collaborations to reduce the population's economic and health burden, specifically regarding neurological/brain, spine, and mental disorders. © 2021 - IOS Press. All rights reserved.
Other Related Docs
20. Stem Cells and Targeted Gene Therapy in Brain and Spinal Cord Tumors, Advances in Experimental Medicine and Biology (2023)